Founded in 1996, Dalian Zhenao Group is primarily engaged in the research and development of biotechnology, gene technology, and the manufacturing of bio-pharmaceuticals and health products. Its total investment accounts for 2.16 billion yuan. Zhenao Group has China's largest nucleic acid manufacture base, with an annual production capacity of 15 billion yuan.
Call for feedback:
2026 Share your views on innovation in China